Global Gabapentin Drug Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Gabapentin Drug competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Gabapentin is a central nervous system medication that primarily modulates the ?2-? subunit of voltage-gated calcium channels. Initially developed as an adjunct for partial seizures, it has since been widely adopted for neuropathic pain, restless legs syndrome, and other indications. With a favorable safety and tolerability profile, low potential for drug-drug interactions, and suitability for long-term maintenance therapy, gabapentin has become a cornerstone in chronic pain and neurological care. Clinically, it is used both as monotherapy for symptom control and as part of combination regimens or extended-release formulations to improve adherence and convenience. Against evolving formularies and reimbursement landscapes globally, gabapentin has transitioned from a single-use prescription into a diversified commercial portfolio with resilient demand foundations and multiple avenues for lifecycle extension. In 2024, global Gabapentin production reached approximately 12941 m units, with an average global market price of around US$ 0.11 perunit.The average gross profit margin of this product is 45%.Gabapentin benefits from a healthcare environment increasingly focused on chronic disease management, opioid-sparing strategies, and rational pharmacotherapy. Policy shifts that limit opioid prescriptions have opened therapeutic space for non-addictive analgesics, including gabapentin. Pharmaceutical firms are pursuing lifecycle management through formulation upgrades, prodrug development, and combination products, while digital patient management and telemedicine improve long-term adherence. Mature markets? accumulated real-world safety and effectiveness evidence supports guideline inclusion and reimbursement negotiations, attracting continued corporate and investor interest in the category.The market faces regulatory and competitive headwinds. In some jurisdictions, tighter controls and monitoring?driven by concerns about misuse?have increased prescribing complexity and distribution oversight. Generic competition exerts downward price pressure, compressing margins for branded products and raising the hurdle for recouping investment in novel formulations. Supply-side concentration of API and intermediates introduces vulnerability to shortages or trade disruptions. Additionally, scientific debates over off-label uses and long-term safety can influence guideline and payer decisions, adding volatility to market prospects.Downstream demand is expanding both in breadth and depth. Core indications such as neuropathic pain and post-herpetic neuralgia remain steady, while primary care adoption and chronic disease management are increasing gabapentin?s presence at the community level. Clinicians and patients prioritize dosing convenience and adherence, driving demand for extended-release and combination formulations. The rise of e-prescribing and online pharmacies is reshaping procurement channels, elevating the importance of product differentiation and brand trust in competitive dynamics.Gabapentin manufacture depends on several organic intermediates and fine chemical inputs; while synthetic routes are established, they require controlled processes and quality-assured supply. Asia?particularly China and India?dominates API and intermediate manufacturing capacity, offering cost advantages but also exposure to regulatory and input-cost volatility. Leading firms mitigate risk through supplier diversification, localization of inventories, and strategic upstream partnerships; investments in greener synthetic routes and process intensification further improve cost and environmental profiles. Raw material stability and compliance therefore critically influence cost structure, delivery reliability, and market agility.
The global Gabapentin Drug market size was estimated at USD 1424.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gabapentin Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gabapentin Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gabapentin Drug market.
Global Gabapentin Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Depomed
TEVA
Viatris
Alvogen
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Market Segmentation (by Type)
Capsule
Tablet
Oral Solution
Market Segmentation (by Application)
Hospital
Retail Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gabapentin Drug Market
Overview of the regional outlook of the Gabapentin Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gabapentin Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gabapentin Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Gabapentin Drug market size was estimated at USD 1424.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gabapentin Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gabapentin Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gabapentin Drug market.
Global Gabapentin Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Depomed
TEVA
Viatris
Alvogen
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Market Segmentation (by Type)
Capsule
Tablet
Oral Solution
Market Segmentation (by Application)
Hospital
Retail Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gabapentin Drug Market
Overview of the regional outlook of the Gabapentin Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gabapentin Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gabapentin Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gabapentin Drug
1.2 Key Market Segments
1.2.1 Gabapentin Drug Segment by Type
1.2.2 Gabapentin Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GABAPENTIN DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gabapentin Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gabapentin Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GABAPENTIN DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gabapentin Drug Product Life Cycle
3.3 Global Gabapentin Drug Sales by Manufacturers (2020-2025)
3.4 Global Gabapentin Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gabapentin Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gabapentin Drug Market Competitive Situation and Trends
3.8.1 Gabapentin Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gabapentin Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GABAPENTIN DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gabapentin Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GABAPENTIN DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gabapentin Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gabapentin Drug Market
5.7 ESG Ratings of Leading Companies
6 GABAPENTIN DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gabapentin Drug Sales Market Share by Type (2020-2025)
6.3 Global Gabapentin Drug Market Size by Type (2020-2025)
6.4 Global Gabapentin Drug Price by Type (2020-2025)
7 GABAPENTIN DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gabapentin Drug Market Sales by Application (2020-2025)
7.3 Global Gabapentin Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Gabapentin Drug Sales Growth Rate by Application (2020-2025)
8 GABAPENTIN DRUG MARKET SALES BY REGION
8.1 Global Gabapentin Drug Sales by Region
8.1.1 Global Gabapentin Drug Sales by Region
8.1.2 Global Gabapentin Drug Sales Market Share by Region
8.2 Global Gabapentin Drug Market Size by Region
8.2.1 Global Gabapentin Drug Market Size by Region
8.2.2 Global Gabapentin Drug Market Size by Region
8.3 North America
8.3.1 North America Gabapentin Drug Sales by Country
8.3.2 North America Gabapentin Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gabapentin Drug Sales by Country
8.4.2 Europe Gabapentin Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gabapentin Drug Sales by Region
8.5.2 Asia Pacific Gabapentin Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gabapentin Drug Sales by Country
8.6.2 South America Gabapentin Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gabapentin Drug Sales by Region
8.7.2 Middle East and Africa Gabapentin Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GABAPENTIN DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Gabapentin Drug by Region(2020-2025)
9.2 Global Gabapentin Drug Revenue Market Share by Region (2020-2025)
9.3 Global Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gabapentin Drug Production
9.4.1 North America Gabapentin Drug Production Growth Rate (2020-2025)
9.4.2 North America Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gabapentin Drug Production
9.5.1 Europe Gabapentin Drug Production Growth Rate (2020-2025)
9.5.2 Europe Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gabapentin Drug Production (2020-2025)
9.6.1 Japan Gabapentin Drug Production Growth Rate (2020-2025)
9.6.2 Japan Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gabapentin Drug Production (2020-2025)
9.7.1 China Gabapentin Drug Production Growth Rate (2020-2025)
9.7.2 China Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Gabapentin Drug Product Overview
10.1.3 Pfizer Gabapentin Drug Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Depomed
10.2.1 Depomed Basic Information
10.2.2 Depomed Gabapentin Drug Product Overview
10.2.3 Depomed Gabapentin Drug Product Market Performance
10.2.4 Depomed Business Overview
10.2.5 Depomed SWOT Analysis
10.2.6 Depomed Recent Developments
10.3 TEVA
10.3.1 TEVA Basic Information
10.3.2 TEVA Gabapentin Drug Product Overview
10.3.3 TEVA Gabapentin Drug Product Market Performance
10.3.4 TEVA Business Overview
10.3.5 TEVA SWOT Analysis
10.3.6 TEVA Recent Developments
10.4 Viatris
10.4.1 Viatris Basic Information
10.4.2 Viatris Gabapentin Drug Product Overview
10.4.3 Viatris Gabapentin Drug Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 Alvogen
10.5.1 Alvogen Basic Information
10.5.2 Alvogen Gabapentin Drug Product Overview
10.5.3 Alvogen Gabapentin Drug Product Market Performance
10.5.4 Alvogen Business Overview
10.5.5 Alvogen Recent Developments
10.6 Novartis
10.6.1 Novartis Basic Information
10.6.2 Novartis Gabapentin Drug Product Overview
10.6.3 Novartis Gabapentin Drug Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 Apotex
10.7.1 Apotex Basic Information
10.7.2 Apotex Gabapentin Drug Product Overview
10.7.3 Apotex Gabapentin Drug Product Market Performance
10.7.4 Apotex Business Overview
10.7.5 Apotex Recent Developments
10.8 Sun Pharmaceutical
10.8.1 Sun Pharmaceutical Basic Information
10.8.2 Sun Pharmaceutical Gabapentin Drug Product Overview
10.8.3 Sun Pharmaceutical Gabapentin Drug Product Market Performance
10.8.4 Sun Pharmaceutical Business Overview
10.8.5 Sun Pharmaceutical Recent Developments
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Basic Information
10.9.2 Aurobindo Pharma Gabapentin Drug Product Overview
10.9.3 Aurobindo Pharma Gabapentin Drug Product Market Performance
10.9.4 Aurobindo Pharma Business Overview
10.9.5 Aurobindo Pharma Recent Developments
10.10 Intas
10.10.1 Intas Basic Information
10.10.2 Intas Gabapentin Drug Product Overview
10.10.3 Intas Gabapentin Drug Product Market Performance
10.10.4 Intas Business Overview
10.10.5 Intas Recent Developments
10.11 Amneal
10.11.1 Amneal Basic Information
10.11.2 Amneal Gabapentin Drug Product Overview
10.11.3 Amneal Gabapentin Drug Product Market Performance
10.11.4 Amneal Business Overview
10.11.5 Amneal Recent Developments
10.12 Marksans Pharma
10.12.1 Marksans Pharma Basic Information
10.12.2 Marksans Pharma Gabapentin Drug Product Overview
10.12.3 Marksans Pharma Gabapentin Drug Product Market Performance
10.12.4 Marksans Pharma Business Overview
10.12.5 Marksans Pharma Recent Developments
10.13 Glenmark
10.13.1 Glenmark Basic Information
10.13.2 Glenmark Gabapentin Drug Product Overview
10.13.3 Glenmark Gabapentin Drug Product Market Performance
10.13.4 Glenmark Business Overview
10.13.5 Glenmark Recent Developments
10.14 Alkem
10.14.1 Alkem Basic Information
10.14.2 Alkem Gabapentin Drug Product Overview
10.14.3 Alkem Gabapentin Drug Product Market Performance
10.14.4 Alkem Business Overview
10.14.5 Alkem Recent Developments
10.15 Jiangsu Enhua
10.15.1 Jiangsu Enhua Basic Information
10.15.2 Jiangsu Enhua Gabapentin Drug Product Overview
10.15.3 Jiangsu Enhua Gabapentin Drug Product Market Performance
10.15.4 Jiangsu Enhua Business Overview
10.15.5 Jiangsu Enhua Recent Developments
10.16 Jiangsu Hengrui
10.16.1 Jiangsu Hengrui Basic Information
10.16.2 Jiangsu Hengrui Gabapentin Drug Product Overview
10.16.3 Jiangsu Hengrui Gabapentin Drug Product Market Performance
10.16.4 Jiangsu Hengrui Business Overview
10.16.5 Jiangsu Hengrui Recent Developments
10.17 Sailike
10.17.1 Sailike Basic Information
10.17.2 Sailike Gabapentin Drug Product Overview
10.17.3 Sailike Gabapentin Drug Product Market Performance
10.17.4 Sailike Business Overview
10.17.5 Sailike Recent Developments
11 GABAPENTIN DRUG MARKET FORECAST BY REGION
11.1 Global Gabapentin Drug Market Size Forecast
11.2 Global Gabapentin Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gabapentin Drug Market Size Forecast by Country
11.2.3 Asia Pacific Gabapentin Drug Market Size Forecast by Region
11.2.4 South America Gabapentin Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gabapentin Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gabapentin Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gabapentin Drug by Type (2026-2035)
12.1.2 Global Gabapentin Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gabapentin Drug by Type (2026-2035)
12.2 Global Gabapentin Drug Market Forecast by Application (2026-2035)
12.2.1 Global Gabapentin Drug Sales (K MT) Forecast by Application
12.2.2 Global Gabapentin Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gabapentin Drug
1.2 Key Market Segments
1.2.1 Gabapentin Drug Segment by Type
1.2.2 Gabapentin Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GABAPENTIN DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gabapentin Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gabapentin Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GABAPENTIN DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gabapentin Drug Product Life Cycle
3.3 Global Gabapentin Drug Sales by Manufacturers (2020-2025)
3.4 Global Gabapentin Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gabapentin Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gabapentin Drug Market Competitive Situation and Trends
3.8.1 Gabapentin Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gabapentin Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GABAPENTIN DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gabapentin Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GABAPENTIN DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gabapentin Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gabapentin Drug Market
5.7 ESG Ratings of Leading Companies
6 GABAPENTIN DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gabapentin Drug Sales Market Share by Type (2020-2025)
6.3 Global Gabapentin Drug Market Size by Type (2020-2025)
6.4 Global Gabapentin Drug Price by Type (2020-2025)
7 GABAPENTIN DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gabapentin Drug Market Sales by Application (2020-2025)
7.3 Global Gabapentin Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Gabapentin Drug Sales Growth Rate by Application (2020-2025)
8 GABAPENTIN DRUG MARKET SALES BY REGION
8.1 Global Gabapentin Drug Sales by Region
8.1.1 Global Gabapentin Drug Sales by Region
8.1.2 Global Gabapentin Drug Sales Market Share by Region
8.2 Global Gabapentin Drug Market Size by Region
8.2.1 Global Gabapentin Drug Market Size by Region
8.2.2 Global Gabapentin Drug Market Size by Region
8.3 North America
8.3.1 North America Gabapentin Drug Sales by Country
8.3.2 North America Gabapentin Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gabapentin Drug Sales by Country
8.4.2 Europe Gabapentin Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gabapentin Drug Sales by Region
8.5.2 Asia Pacific Gabapentin Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gabapentin Drug Sales by Country
8.6.2 South America Gabapentin Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gabapentin Drug Sales by Region
8.7.2 Middle East and Africa Gabapentin Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GABAPENTIN DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Gabapentin Drug by Region(2020-2025)
9.2 Global Gabapentin Drug Revenue Market Share by Region (2020-2025)
9.3 Global Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gabapentin Drug Production
9.4.1 North America Gabapentin Drug Production Growth Rate (2020-2025)
9.4.2 North America Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gabapentin Drug Production
9.5.1 Europe Gabapentin Drug Production Growth Rate (2020-2025)
9.5.2 Europe Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gabapentin Drug Production (2020-2025)
9.6.1 Japan Gabapentin Drug Production Growth Rate (2020-2025)
9.6.2 Japan Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gabapentin Drug Production (2020-2025)
9.7.1 China Gabapentin Drug Production Growth Rate (2020-2025)
9.7.2 China Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Gabapentin Drug Product Overview
10.1.3 Pfizer Gabapentin Drug Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Depomed
10.2.1 Depomed Basic Information
10.2.2 Depomed Gabapentin Drug Product Overview
10.2.3 Depomed Gabapentin Drug Product Market Performance
10.2.4 Depomed Business Overview
10.2.5 Depomed SWOT Analysis
10.2.6 Depomed Recent Developments
10.3 TEVA
10.3.1 TEVA Basic Information
10.3.2 TEVA Gabapentin Drug Product Overview
10.3.3 TEVA Gabapentin Drug Product Market Performance
10.3.4 TEVA Business Overview
10.3.5 TEVA SWOT Analysis
10.3.6 TEVA Recent Developments
10.4 Viatris
10.4.1 Viatris Basic Information
10.4.2 Viatris Gabapentin Drug Product Overview
10.4.3 Viatris Gabapentin Drug Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 Alvogen
10.5.1 Alvogen Basic Information
10.5.2 Alvogen Gabapentin Drug Product Overview
10.5.3 Alvogen Gabapentin Drug Product Market Performance
10.5.4 Alvogen Business Overview
10.5.5 Alvogen Recent Developments
10.6 Novartis
10.6.1 Novartis Basic Information
10.6.2 Novartis Gabapentin Drug Product Overview
10.6.3 Novartis Gabapentin Drug Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 Apotex
10.7.1 Apotex Basic Information
10.7.2 Apotex Gabapentin Drug Product Overview
10.7.3 Apotex Gabapentin Drug Product Market Performance
10.7.4 Apotex Business Overview
10.7.5 Apotex Recent Developments
10.8 Sun Pharmaceutical
10.8.1 Sun Pharmaceutical Basic Information
10.8.2 Sun Pharmaceutical Gabapentin Drug Product Overview
10.8.3 Sun Pharmaceutical Gabapentin Drug Product Market Performance
10.8.4 Sun Pharmaceutical Business Overview
10.8.5 Sun Pharmaceutical Recent Developments
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Basic Information
10.9.2 Aurobindo Pharma Gabapentin Drug Product Overview
10.9.3 Aurobindo Pharma Gabapentin Drug Product Market Performance
10.9.4 Aurobindo Pharma Business Overview
10.9.5 Aurobindo Pharma Recent Developments
10.10 Intas
10.10.1 Intas Basic Information
10.10.2 Intas Gabapentin Drug Product Overview
10.10.3 Intas Gabapentin Drug Product Market Performance
10.10.4 Intas Business Overview
10.10.5 Intas Recent Developments
10.11 Amneal
10.11.1 Amneal Basic Information
10.11.2 Amneal Gabapentin Drug Product Overview
10.11.3 Amneal Gabapentin Drug Product Market Performance
10.11.4 Amneal Business Overview
10.11.5 Amneal Recent Developments
10.12 Marksans Pharma
10.12.1 Marksans Pharma Basic Information
10.12.2 Marksans Pharma Gabapentin Drug Product Overview
10.12.3 Marksans Pharma Gabapentin Drug Product Market Performance
10.12.4 Marksans Pharma Business Overview
10.12.5 Marksans Pharma Recent Developments
10.13 Glenmark
10.13.1 Glenmark Basic Information
10.13.2 Glenmark Gabapentin Drug Product Overview
10.13.3 Glenmark Gabapentin Drug Product Market Performance
10.13.4 Glenmark Business Overview
10.13.5 Glenmark Recent Developments
10.14 Alkem
10.14.1 Alkem Basic Information
10.14.2 Alkem Gabapentin Drug Product Overview
10.14.3 Alkem Gabapentin Drug Product Market Performance
10.14.4 Alkem Business Overview
10.14.5 Alkem Recent Developments
10.15 Jiangsu Enhua
10.15.1 Jiangsu Enhua Basic Information
10.15.2 Jiangsu Enhua Gabapentin Drug Product Overview
10.15.3 Jiangsu Enhua Gabapentin Drug Product Market Performance
10.15.4 Jiangsu Enhua Business Overview
10.15.5 Jiangsu Enhua Recent Developments
10.16 Jiangsu Hengrui
10.16.1 Jiangsu Hengrui Basic Information
10.16.2 Jiangsu Hengrui Gabapentin Drug Product Overview
10.16.3 Jiangsu Hengrui Gabapentin Drug Product Market Performance
10.16.4 Jiangsu Hengrui Business Overview
10.16.5 Jiangsu Hengrui Recent Developments
10.17 Sailike
10.17.1 Sailike Basic Information
10.17.2 Sailike Gabapentin Drug Product Overview
10.17.3 Sailike Gabapentin Drug Product Market Performance
10.17.4 Sailike Business Overview
10.17.5 Sailike Recent Developments
11 GABAPENTIN DRUG MARKET FORECAST BY REGION
11.1 Global Gabapentin Drug Market Size Forecast
11.2 Global Gabapentin Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gabapentin Drug Market Size Forecast by Country
11.2.3 Asia Pacific Gabapentin Drug Market Size Forecast by Region
11.2.4 South America Gabapentin Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gabapentin Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gabapentin Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gabapentin Drug by Type (2026-2035)
12.1.2 Global Gabapentin Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gabapentin Drug by Type (2026-2035)
12.2 Global Gabapentin Drug Market Forecast by Application (2026-2035)
12.2.1 Global Gabapentin Drug Sales (K MT) Forecast by Application
12.2.2 Global Gabapentin Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gabapentin Drug Market Size by Type (M USD)
Table 4. Global Gabapentin Drug Market Size by Application
Table 5. Gabapentin Drug Market Size Comparison by Region (M USD)
Table 6. Global Gabapentin Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gabapentin Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gabapentin Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gabapentin Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2025)
Table 11. Global Market Gabapentin Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gabapentin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gabapentin Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gabapentin Drug Sales by Type (K MT)
Table 27. Global Gabapentin Drug Market Size by Type (M USD)
Table 28. Global Gabapentin Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Gabapentin Drug Sales Market Share by Type (2020-2025)
Table 30. Global Gabapentin Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Gabapentin Drug Market Share by Type (2020-2025)
Table 32. Global Gabapentin Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Gabapentin Drug Sales (K MT) by Application
Table 34. Global Gabapentin Drug Market Size by Application
Table 35. Global Gabapentin Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Gabapentin Drug Sales Market Share by Application (2020-2025)
Table 37. Global Gabapentin Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gabapentin Drug Market Share by Application (2020-2025)
Table 39. Global Gabapentin Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Gabapentin Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Gabapentin Drug Sales Market Share by Region (2020-2025)
Table 42. Global Gabapentin Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gabapentin Drug Market Size by Region (2020-2025)
Table 44. North America Gabapentin Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Gabapentin Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gabapentin Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gabapentin Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gabapentin Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gabapentin Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gabapentin Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Gabapentin Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gabapentin Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gabapentin Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gabapentin Drug Production (K MT) by Region(2020-2025)
Table 55. Global Gabapentin Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gabapentin Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Gabapentin Drug Product Overview
Table 64. Pfizer Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Depomed Basic Information
Table 69. Depomed Gabapentin Drug Product Overview
Table 70. Depomed Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Depomed Business Overview
Table 72. Depomed SWOT Analysis
Table 73. Depomed Recent Developments
Table 74. TEVA Basic Information
Table 75. TEVA Gabapentin Drug Product Overview
Table 76. TEVA Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. TEVA Business Overview
Table 78. TEVA SWOT Analysis
Table 79. TEVA Recent Developments
Table 80. Viatris Basic Information
Table 81. Viatris Gabapentin Drug Product Overview
Table 82. Viatris Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Viatris Business Overview
Table 84. Viatris Recent Developments
Table 85. Alvogen Basic Information
Table 86. Alvogen Gabapentin Drug Product Overview
Table 87. Alvogen Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Alvogen Business Overview
Table 89. Alvogen Recent Developments
Table 90. Novartis Basic Information
Table 91. Novartis Gabapentin Drug Product Overview
Table 92. Novartis Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Business Overview
Table 94. Novartis Recent Developments
Table 95. Apotex Basic Information
Table 96. Apotex Gabapentin Drug Product Overview
Table 97. Apotex Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Apotex Business Overview
Table 99. Apotex Recent Developments
Table 100. Sun Pharmaceutical Basic Information
Table 101. Sun Pharmaceutical Gabapentin Drug Product Overview
Table 102. Sun Pharmaceutical Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sun Pharmaceutical Business Overview
Table 104. Sun Pharmaceutical Recent Developments
Table 105. Aurobindo Pharma Basic Information
Table 106. Aurobindo Pharma Gabapentin Drug Product Overview
Table 107. Aurobindo Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Recent Developments
Table 110. Intas Basic Information
Table 111. Intas Gabapentin Drug Product Overview
Table 112. Intas Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Intas Business Overview
Table 114. Intas Recent Developments
Table 115. Amneal Basic Information
Table 116. Amneal Gabapentin Drug Product Overview
Table 117. Amneal Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Amneal Business Overview
Table 119. Amneal Recent Developments
Table 120. Marksans Pharma Basic Information
Table 121. Marksans Pharma Gabapentin Drug Product Overview
Table 122. Marksans Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Marksans Pharma Business Overview
Table 124. Marksans Pharma Recent Developments
Table 125. Glenmark Basic Information
Table 126. Glenmark Gabapentin Drug Product Overview
Table 127. Glenmark Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Glenmark Business Overview
Table 129. Glenmark Recent Developments
Table 130. Alkem Basic Information
Table 131. Alkem Gabapentin Drug Product Overview
Table 132. Alkem Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Alkem Business Overview
Table 134. Alkem Recent Developments
Table 135. Jiangsu Enhua Basic Information
Table 136. Jiangsu Enhua Gabapentin Drug Product Overview
Table 137. Jiangsu Enhua Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Jiangsu Enhua Business Overview
Table 139. Jiangsu Enhua Recent Developments
Table 140. Jiangsu Hengrui Basic Information
Table 141. Jiangsu Hengrui Gabapentin Drug Product Overview
Table 142. Jiangsu Hengrui Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Jiangsu Hengrui Business Overview
Table 144. Jiangsu Hengrui Recent Developments
Table 145. Sailike Basic Information
Table 146. Sailike Gabapentin Drug Product Overview
Table 147. Sailike Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Sailike Business Overview
Table 149. Sailike Recent Developments
Table 150. Global Gabapentin Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Gabapentin Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Gabapentin Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Gabapentin Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Gabapentin Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Gabapentin Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Gabapentin Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Gabapentin Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Gabapentin Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Gabapentin Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Gabapentin Drug Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Gabapentin Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Gabapentin Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Gabapentin Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Gabapentin Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Gabapentin Drug Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Gabapentin Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gabapentin Drug Market Size by Type (M USD)
Table 4. Global Gabapentin Drug Market Size by Application
Table 5. Gabapentin Drug Market Size Comparison by Region (M USD)
Table 6. Global Gabapentin Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gabapentin Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gabapentin Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gabapentin Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2025)
Table 11. Global Market Gabapentin Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gabapentin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gabapentin Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gabapentin Drug Sales by Type (K MT)
Table 27. Global Gabapentin Drug Market Size by Type (M USD)
Table 28. Global Gabapentin Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Gabapentin Drug Sales Market Share by Type (2020-2025)
Table 30. Global Gabapentin Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Gabapentin Drug Market Share by Type (2020-2025)
Table 32. Global Gabapentin Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Gabapentin Drug Sales (K MT) by Application
Table 34. Global Gabapentin Drug Market Size by Application
Table 35. Global Gabapentin Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Gabapentin Drug Sales Market Share by Application (2020-2025)
Table 37. Global Gabapentin Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gabapentin Drug Market Share by Application (2020-2025)
Table 39. Global Gabapentin Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Gabapentin Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Gabapentin Drug Sales Market Share by Region (2020-2025)
Table 42. Global Gabapentin Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gabapentin Drug Market Size by Region (2020-2025)
Table 44. North America Gabapentin Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Gabapentin Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gabapentin Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gabapentin Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gabapentin Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gabapentin Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gabapentin Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Gabapentin Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gabapentin Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gabapentin Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gabapentin Drug Production (K MT) by Region(2020-2025)
Table 55. Global Gabapentin Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gabapentin Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Gabapentin Drug Product Overview
Table 64. Pfizer Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Depomed Basic Information
Table 69. Depomed Gabapentin Drug Product Overview
Table 70. Depomed Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Depomed Business Overview
Table 72. Depomed SWOT Analysis
Table 73. Depomed Recent Developments
Table 74. TEVA Basic Information
Table 75. TEVA Gabapentin Drug Product Overview
Table 76. TEVA Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. TEVA Business Overview
Table 78. TEVA SWOT Analysis
Table 79. TEVA Recent Developments
Table 80. Viatris Basic Information
Table 81. Viatris Gabapentin Drug Product Overview
Table 82. Viatris Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Viatris Business Overview
Table 84. Viatris Recent Developments
Table 85. Alvogen Basic Information
Table 86. Alvogen Gabapentin Drug Product Overview
Table 87. Alvogen Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Alvogen Business Overview
Table 89. Alvogen Recent Developments
Table 90. Novartis Basic Information
Table 91. Novartis Gabapentin Drug Product Overview
Table 92. Novartis Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Business Overview
Table 94. Novartis Recent Developments
Table 95. Apotex Basic Information
Table 96. Apotex Gabapentin Drug Product Overview
Table 97. Apotex Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Apotex Business Overview
Table 99. Apotex Recent Developments
Table 100. Sun Pharmaceutical Basic Information
Table 101. Sun Pharmaceutical Gabapentin Drug Product Overview
Table 102. Sun Pharmaceutical Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sun Pharmaceutical Business Overview
Table 104. Sun Pharmaceutical Recent Developments
Table 105. Aurobindo Pharma Basic Information
Table 106. Aurobindo Pharma Gabapentin Drug Product Overview
Table 107. Aurobindo Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Recent Developments
Table 110. Intas Basic Information
Table 111. Intas Gabapentin Drug Product Overview
Table 112. Intas Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Intas Business Overview
Table 114. Intas Recent Developments
Table 115. Amneal Basic Information
Table 116. Amneal Gabapentin Drug Product Overview
Table 117. Amneal Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Amneal Business Overview
Table 119. Amneal Recent Developments
Table 120. Marksans Pharma Basic Information
Table 121. Marksans Pharma Gabapentin Drug Product Overview
Table 122. Marksans Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Marksans Pharma Business Overview
Table 124. Marksans Pharma Recent Developments
Table 125. Glenmark Basic Information
Table 126. Glenmark Gabapentin Drug Product Overview
Table 127. Glenmark Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Glenmark Business Overview
Table 129. Glenmark Recent Developments
Table 130. Alkem Basic Information
Table 131. Alkem Gabapentin Drug Product Overview
Table 132. Alkem Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Alkem Business Overview
Table 134. Alkem Recent Developments
Table 135. Jiangsu Enhua Basic Information
Table 136. Jiangsu Enhua Gabapentin Drug Product Overview
Table 137. Jiangsu Enhua Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Jiangsu Enhua Business Overview
Table 139. Jiangsu Enhua Recent Developments
Table 140. Jiangsu Hengrui Basic Information
Table 141. Jiangsu Hengrui Gabapentin Drug Product Overview
Table 142. Jiangsu Hengrui Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Jiangsu Hengrui Business Overview
Table 144. Jiangsu Hengrui Recent Developments
Table 145. Sailike Basic Information
Table 146. Sailike Gabapentin Drug Product Overview
Table 147. Sailike Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Sailike Business Overview
Table 149. Sailike Recent Developments
Table 150. Global Gabapentin Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Gabapentin Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Gabapentin Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Gabapentin Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Gabapentin Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Gabapentin Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Gabapentin Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Gabapentin Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Gabapentin Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Gabapentin Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Gabapentin Drug Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Gabapentin Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Gabapentin Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Gabapentin Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Gabapentin Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Gabapentin Drug Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Gabapentin Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gabapentin Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gabapentin Drug Market Size (M USD), 2025-2035
Figure 5. Global Gabapentin Drug Market Size (M USD) (2020-2035)
Figure 6. Global Gabapentin Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gabapentin Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gabapentin Drug Product Life Cycle
Figure 13. Gabapentin Drug Sales Share by Manufacturers in 2025
Figure 14. Global Gabapentin Drug Revenue Share by Manufacturers in 2025
Figure 15. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gabapentin Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gabapentin Drug Revenue in 2025
Figure 18. Industry Chain Map of Gabapentin Drug
Figure 19. Global Gabapentin Drug Market PEST Analysis
Figure 20. Global Gabapentin Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gabapentin Drug Market Share by Type
Figure 27. Sales Market Share of Gabapentin Drug by Type (2020-2025)
Figure 28. Sales Market Share of Gabapentin Drug by Type in 2025
Figure 29. Market Share of Gabapentin Drug by Type (2020-2025)
Figure 30. Market Share of Gabapentin Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gabapentin Drug Market Share by Application
Figure 33. Global Gabapentin Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Gabapentin Drug Sales Market Share by Application in 2025
Figure 35. Global Gabapentin Drug Market Share by Application (2020-2025)
Figure 36. Global Gabapentin Drug Market Share by Application in 2025
Figure 37. Global Gabapentin Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gabapentin Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Gabapentin Drug Market Size by Region (2020-2025)
Figure 40. North America Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gabapentin Drug Sales Market Share by Country in 2024
Figure 43. North America Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gabapentin Drug Market Size by Country in 2024
Figure 45. U.S. Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gabapentin Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gabapentin Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gabapentin Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gabapentin Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gabapentin Drug Sales Market Share by Country in 2024
Figure 53. Europe Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gabapentin Drug Market Size by Country in 2024
Figure 55. Germany Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gabapentin Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gabapentin Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gabapentin Drug Market Size by Region in 2024
Figure 68. China Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gabapentin Drug Sales and Growth Rate (K MT)
Figure 79. South America Gabapentin Drug Sales Market Share by Country in 2024
Figure 80. South America Gabapentin Drug Market Size and Growth Rate (M USD)
Figure 81. South America Gabapentin Drug Market Size by Country in 2024
Figure 82. Brazil Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gabapentin Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gabapentin Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gabapentin Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gabapentin Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gabapentin Drug Production Market Share by Region (2020-2025)
Figure 103. North America Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gabapentin Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gabapentin Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gabapentin Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gabapentin Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Gabapentin Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Gabapentin Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Gabapentin Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gabapentin Drug Market Size (M USD), 2025-2035
Figure 5. Global Gabapentin Drug Market Size (M USD) (2020-2035)
Figure 6. Global Gabapentin Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gabapentin Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gabapentin Drug Product Life Cycle
Figure 13. Gabapentin Drug Sales Share by Manufacturers in 2025
Figure 14. Global Gabapentin Drug Revenue Share by Manufacturers in 2025
Figure 15. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gabapentin Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gabapentin Drug Revenue in 2025
Figure 18. Industry Chain Map of Gabapentin Drug
Figure 19. Global Gabapentin Drug Market PEST Analysis
Figure 20. Global Gabapentin Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gabapentin Drug Market Share by Type
Figure 27. Sales Market Share of Gabapentin Drug by Type (2020-2025)
Figure 28. Sales Market Share of Gabapentin Drug by Type in 2025
Figure 29. Market Share of Gabapentin Drug by Type (2020-2025)
Figure 30. Market Share of Gabapentin Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gabapentin Drug Market Share by Application
Figure 33. Global Gabapentin Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Gabapentin Drug Sales Market Share by Application in 2025
Figure 35. Global Gabapentin Drug Market Share by Application (2020-2025)
Figure 36. Global Gabapentin Drug Market Share by Application in 2025
Figure 37. Global Gabapentin Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gabapentin Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Gabapentin Drug Market Size by Region (2020-2025)
Figure 40. North America Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gabapentin Drug Sales Market Share by Country in 2024
Figure 43. North America Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gabapentin Drug Market Size by Country in 2024
Figure 45. U.S. Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gabapentin Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gabapentin Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gabapentin Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gabapentin Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gabapentin Drug Sales Market Share by Country in 2024
Figure 53. Europe Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gabapentin Drug Market Size by Country in 2024
Figure 55. Germany Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gabapentin Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gabapentin Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gabapentin Drug Market Size by Region in 2024
Figure 68. China Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gabapentin Drug Sales and Growth Rate (K MT)
Figure 79. South America Gabapentin Drug Sales Market Share by Country in 2024
Figure 80. South America Gabapentin Drug Market Size and Growth Rate (M USD)
Figure 81. South America Gabapentin Drug Market Size by Country in 2024
Figure 82. Brazil Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gabapentin Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gabapentin Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gabapentin Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gabapentin Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gabapentin Drug Production Market Share by Region (2020-2025)
Figure 103. North America Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gabapentin Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gabapentin Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gabapentin Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gabapentin Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Gabapentin Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Gabapentin Drug Market Share Forecast by Application (2026-2035)
